Icon

JOENJA (NDA217759)- (EQ 70MG BASE)

LENIOLISIB PHOSPHATE PHARMING
EQ 70MG BASE
No No
2032-Feb-19 2028-Mar-24
None None
None No
JOENJA is a kinase inhibitor indicated for the treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 70MG BASE ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.